
New Studies Around CBD
, by Anndrena Benajmin, 8 min reading time

, by Anndrena Benajmin, 8 min reading time
Meta Title: New CBD Studies 2026: Latest Research, Clinical Trials & Scientific Evidence
Meta Description: Explore the newest CBD research studies, clinical trials, and scientific discoveries. Learn what recent evidence says about CBD benefits, safety, and future medical use.
Cannabidiol (CBD) research has grown rapidly over the last few years. Scientists are now moving beyond early wellness claims into large clinical trials and medical research.
Experts predict cannabis and CBD clinical trials will expand significantly by 2026 due to rising patient demand and improved research infrastructure.
👉 https://ccrps.org/clinical-research-blog/why-cannabis-clinical-trials-will-explode-by-2026-and-who-will-lead
This shift means newer studies focus on:
Neurological disorders
Anxiety and sleep
Pain management
Autism research
Safety and long-term effects
Recent scientific reviews show CBD may have neuroprotective and anti-inflammatory properties, making it a strong candidate for neurological treatments.
A 2026 neurology review reported CBD demonstrates:
Antioxidant effects
Anti-inflammatory activity
Potential neuroprotective benefits in neurological disorders
👉 https://pmc.ncbi.nlm.nih.gov/articles/PMC12943572/
One long-term clinical follow-up study involving epilepsy patients found:
Over 50% seizure reduction in 69% of participants
CBD remained generally safe over 20 months
👉 https://pmc.ncbi.nlm.nih.gov/articles/PMC12716290/
This remains one of the strongest areas of evidence supporting medical CBD use.
Researchers continue investigating CBD’s potential calming effects.
A current randomized clinical trial is studying hemp-derived CBD doses between 50–150 mg/day to evaluate improvements in anxiety symptoms and sleep quality.
👉 https://clinicaltrials.gov/study/NCT06672666
Earlier reviews suggest CBD may influence anxiety pathways, though researchers stress that larger trials are still needed.
👉 https://pmc.ncbi.nlm.nih.gov/articles/PMC11481052/
Pain relief remains one of the most studied CBD applications.
A phase-2 randomized trial is currently evaluating whether oral CBD can provide meaningful pain relief as an alternative to opioids.
👉 https://pmc.ncbi.nlm.nih.gov/articles/PMC12472909/
However, some newer findings suggest results are not always consistent:
A 2025 osteoarthritis study found CBD oil was well tolerated but not superior to placebo for pain outcomes.
👉 https://www.frontiersin.org/articles/10.3389/fphar.2025.1657065
This highlights an important trend in modern research: CBD shows potential, but effectiveness varies by condition and dosage.
One of the newest studies (published recently) investigated CBD oil in children with autism.
Researchers found:
Improvements in social interaction
Reduced anxiety levels
Minimal side effects reported
The pilot trial involved a 12-week crossover study and researchers are now calling for larger multi-site trials.
👉 https://www.heraldsun.com.au/news/cbd-oil-improves-social-skills-in-autistic-children-deakin-university-study-finds/news-story/809657c59be613eed5d42414bad3e56d
New laboratory studies suggest cannabinoids may influence metabolic and inflammatory pathways.
A recent study reported CBD reduced liver fat and improved metabolic markers in experimental models, opening potential future treatments for metabolic liver disease.
👉 https://nypost.com/2026/03/09/health/cannabis-compounds-could-reverse-disease-affecting-one-third-of-adults/
Meanwhile, Alzheimer’s research models show CBD may reduce neuroinflammation markers linked to disease progression.
👉 https://www.mdpi.com/1422-0067/26/24/11963
Modern research is also exploring potential risks.
A randomized clinical trial found some participants experienced elevated liver enzymes during daily CBD use, highlighting the need for medical guidance and dosage awareness.
👉 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2836267
Additional reports similarly warn that even low doses may affect liver function in certain individuals.
👉 https://www.euronews.com/health/2025/07/08/cbd-is-becoming-more-popular-but-even-low-doses-may-harm-some-peoples-health-researchers-w
Across recent reviews of thousands of studies:
✅ CBD appears generally well tolerated
✅ Strongest evidence exists for epilepsy treatment
✅ Neurological research is expanding rapidly
⚠️ Evidence for pain, anxiety, and sleep is still developing
⚠️ More large-scale trials are required
A large scientific review also highlighted a gap between public expectations and confirmed clinical evidence.
👉 https://www.sciencedaily.com/releases/2025/12/251211100620.htm
Experts expect the next phase of CBD science to focus on:
Precision dosing
Drug interactions
Long-term safety
Combination cannabinoid therapies
Pharmaceutical-grade CBD medicines
As regulations evolve, researchers believe clinical data will grow rapidly over the next few years.
CBD is strongly supported for certain seizure disorders, while evidence for other uses is still emerging.
Many are promising but mixed — results depend on condition, dosage, and formulation.
Most studies show good tolerability, though monitoring is recommended for high doses or long-term use.
Primary:
new CBD studies
latest CBD research
CBD clinical trials 2026
Secondary:
CBD scientific evidence
CBD research findings
CBD medical research
The newest wave of CBD research shows a transition from hype to science. While early claims were often anecdotal, modern clinical trials are now defining where CBD truly works — and where more evidence is still needed.
The next few years will likely determine whether CBD becomes a mainstream medical therapy or remains primarily a wellness supplement.
This website contains CBD, vape and cannabis-related products.
By continuing, you confirm that you are 18 years of age or older and legally permitted to view this content.
You are not old enough to visit the shop yet.